212 related articles for article (PubMed ID: 12637031)
1. Effects of haloperidol and clozapine on neuropeptide Y-like immunoreactivity in the nucleus accumbens and striatum of rats pretreated with psychostimulants.
Obuchowicz E; Herman ZS
Neuropeptides; 2003 Feb; 37(1):17-24. PubMed ID: 12637031
[TBL] [Abstract][Full Text] [Related]
2. Amphetamine-induced effects on neuropeptide Y in the rat brain.
Obuchowicz E; Turchan J; Przewłocki R; Herman ZS
Pharmacol Rep; 2005; 57(3):321-9. PubMed ID: 15985714
[TBL] [Abstract][Full Text] [Related]
3. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
[TBL] [Abstract][Full Text] [Related]
4. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja.
MacGibbon GA; Lawlor PA; Bravo R; Dragunow M
Brain Res Mol Brain Res; 1994 Apr; 23(1-2):21-32. PubMed ID: 8028480
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat.
Obuchowicz E; Turchan J
Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):51-9. PubMed ID: 10082228
[TBL] [Abstract][Full Text] [Related]
6. Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment.
Servonnet A; Minogianis EA; Bouchard C; Bédard AM; Lévesque D; Rompré PP; Samaha AN
Neuropharmacology; 2017 Sep; 123():10-21. PubMed ID: 28522313
[TBL] [Abstract][Full Text] [Related]
7. Clozapine decreases neuropeptide Y-like immunoreactivity and neuropeptide Y mRNA levels in rat nucleus accumbens.
Obuchowicz E; Turchan J
Eur Neuropsychopharmacol; 1999 Jun; 9(4):329-35. PubMed ID: 10422894
[TBL] [Abstract][Full Text] [Related]
8. Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugs.
Gruber SH; Nomikos GG; Mathé AA
Eur Neuropsychopharmacol; 2006 Dec; 16(8):592-600. PubMed ID: 16524702
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232
[TBL] [Abstract][Full Text] [Related]
10. Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems.
Westwood SC; Hanson GR
J Pharmacol Exp Ther; 1999 Mar; 288(3):1160-6. PubMed ID: 10027854
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus.
Obuchowicz E
Neuropeptides; 1996 Oct; 30(5):471-8. PubMed ID: 8923510
[TBL] [Abstract][Full Text] [Related]
12. Influence of typical and atypical antipsychotics on neuropeptide Y-like immunoreactivity and NPY mRNA expression in rat striatum.
Obuchowicz E; Turchan J
Neuropeptides; 1998 Oct; 32(5):473-80. PubMed ID: 9845010
[TBL] [Abstract][Full Text] [Related]
13. Effects of typical and atypical antipsychotics on neuropeptide Y in rat brain tissue and microdialysates from ventral striatum.
Gruber SH; Mathé AA
J Neurosci Res; 2000 Aug; 61(4):458-63. PubMed ID: 10931533
[TBL] [Abstract][Full Text] [Related]
14. c-Fos identification of neuroanatomical sites associated with haloperidol and clozapine disruption of maternal behavior in the rat.
Zhao C; Li M
Neuroscience; 2010 Apr; 166(4):1043-55. PubMed ID: 20096751
[TBL] [Abstract][Full Text] [Related]
15. Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats.
Meng ZH; Feldpaush DL; Merchant KM
Brain Res Mol Brain Res; 1998 Oct; 61(1-2):39-50. PubMed ID: 9795122
[TBL] [Abstract][Full Text] [Related]
16. Repeated treatment with ascorbate or haloperidol, but not clozapine, elevates extracellular ascorbate in the neostriatum of freely moving rats.
Pierce RC; Clemens AJ; Shapiro LA; Rebec GV
Psychopharmacology (Berl); 1994 Sep; 116(1):103-9. PubMed ID: 7862921
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y mRNA expression levels following chronic olanzapine, clozapine and haloperidol administration in rats.
Huang XF; Deng C; Zavitsanou K
Neuropeptides; 2006 Jun; 40(3):213-9. PubMed ID: 16516965
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
Gygi SP; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
[TBL] [Abstract][Full Text] [Related]
19. Neural basis of the potentiated inhibition of repeated haloperidol and clozapine treatment on the phencyclidine-induced hyperlocomotion.
Zhao C; Sun T; Li M
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):175-82. PubMed ID: 22476004
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
Compton DR; Johnson KM
J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
